Xcout Intel
ARADIGM CORP competitors & alternatives
The 12 closest competitors and alternatives to ARADIGM CORP among pharmaceuticals companies — ranked by similarity to what ARADIGM CORP actually does, not by market-cap band.
Subscribe to see ARADIGM CORP’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ARADIGM CORP
Aradigm Corp is a specialty pharmaceutical company headquartered in Hayward, California, focused on the development and manufacturing of innovative drug delivery technologies.
ARADIGM CORP at a glance
ARADIGM CORP is a pharmaceuticals company headquartered in United States. Its most recent funding round, Series A, raised $20M in December 2025. Xcout tracks 20 named people at ARADIGM CORP, including Will Shrank, M.D. (CEO).
ARADIGM CORP leadership
- Will Shrank, M.D.CEO
- SPENCER CARRUCCIUChief Product Officer
- William ShrankCEO and Co-Founder
- Alec KingstonGrowth & Partnerships
- Annie CollinsCommercial
- Bryan KnightEngineering
14 more named people on record for ARADIGM CORP, with roles, board committees and tenure — see the full roster →
ARADIGM CORP funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $20M | 3 named | |
| Series A | $5M | 3 named | |
| SEC Form D filing | $23M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 ARADIGM CORP competitors
Ranked by semantic similarity — how close each company is to ARADIGM CORP by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Ventaira Pharmaceuticals, formerly known as BattellePharma, is a United States-based specialty pharmaceutical company established in 1997 that specializes in developing, manufacturing, and marketing pharmaceuticals and veterinary medicine. The company utilizes proprietary pulmonary drug delivery technology, such as the Mystic system, to develop inhaled products.
Similar pharmaceuticals company
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company based in San Mateo and Redwood City, California, focused on developing and commercializing therapeutic products.
Similar pharmaceuticals company
Chiesi Farmaceutici is a global biopharmaceutical group that researches, develops, and commercializes therapeutic solutions for patients. The company focuses primarily on respiratory health, rare diseases, and specialty care.
Similar pharmaceuticals company
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
Similar pharmaceuticals company
Crossject SA is an emerging specialty pharmaceutical company based in France and the U.S. that focuses on advanced regulatory and needle-free injection technologies. Headquartered in Dijon, France, the firm develops innovative drug delivery systems.
Similar pharmaceuticals company
Founded in 2003, Nexus Pharmaceuticals is a US-based, family-owned, and minority-led pharmaceutical manufacturer that specializes in innovative processes to produce difficult-to-manufacture injectable drugs.
Similar pharmaceuticals company
Flex Pharma is a specialty pharmaceutical company that develops advanced drug delivery formulations to enhance the bioavailability, tolerability, and dosing flexibility of complex or poorly soluble drugs. The company utilizes its proprietary ElectroNanoSpray (ENS) technology platform to assist pharmaceutical innovators in optimizing drug performance for clinical trials and patient care.
Similar pharmaceuticals company
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company’s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.
Similar pharmaceuticals company
Aarey Drugs & Pharmaceuticals Limited, incorporated in 1990, is an Indian manufacturer of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals serving global export markets.
Similar pharmaceuticals company
Sinotherapeutics Inc. is a high-tech pharmaceutical enterprise focused on the research, commercial production, and sales of advanced drug formulations, including anti-infective, anti-tumor, metabolic, and cardiovascular medications. The company also provides innovative drug formulation CRO and CMO services to global patients and pharmaceutical partners.
Similar pharmaceuticals company
Antares Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on developing first-in-class precision medicines.
Medical - Pharmaceuticals
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ARADIGM CORP and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ARADIGM CORPand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →